DK0667866T3 - 1,4-benzothiazepiner anvendelige som neurologiske midler - Google Patents

1,4-benzothiazepiner anvendelige som neurologiske midler

Info

Publication number
DK0667866T3
DK0667866T3 DK94900113.5T DK94900113T DK0667866T3 DK 0667866 T3 DK0667866 T3 DK 0667866T3 DK 94900113 T DK94900113 T DK 94900113T DK 0667866 T3 DK0667866 T3 DK 0667866T3
Authority
DK
Denmark
Prior art keywords
alkyl
optionally substituted
halo
phenyl
alkoxy
Prior art date
Application number
DK94900113.5T
Other languages
Danish (da)
English (en)
Inventor
John Rosindale Housley
James Edward Jeffery
Kenneth John Nichol
Bruce Jeremy Sargent
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929223443A external-priority patent/GB9223443D0/en
Priority claimed from GB929223441A external-priority patent/GB9223441D0/en
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of DK0667866T3 publication Critical patent/DK0667866T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94900113.5T 1992-11-09 1993-11-06 1,4-benzothiazepiner anvendelige som neurologiske midler DK0667866T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929223443A GB9223443D0 (en) 1992-11-09 1992-11-09 Therapeutic agents
GB929223441A GB9223441D0 (en) 1992-11-09 1992-11-09 Therapeutic agents

Publications (1)

Publication Number Publication Date
DK0667866T3 true DK0667866T3 (da) 1998-05-25

Family

ID=26301938

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94900113.5T DK0667866T3 (da) 1992-11-09 1993-11-06 1,4-benzothiazepiner anvendelige som neurologiske midler

Country Status (22)

Country Link
US (1) US5580866A (sk)
EP (1) EP0667866B1 (sk)
JP (1) JPH08503202A (sk)
KR (1) KR100313649B1 (sk)
AT (1) ATE163927T1 (sk)
BG (1) BG62519B1 (sk)
BR (1) BR9307387A (sk)
CA (1) CA2148584A1 (sk)
CZ (1) CZ288595B6 (sk)
DE (1) DE69317436T2 (sk)
DK (1) DK0667866T3 (sk)
ES (1) ES2113081T3 (sk)
FI (1) FI952204A0 (sk)
GR (1) GR3026386T3 (sk)
HU (1) HUT71819A (sk)
NO (1) NO304467B1 (sk)
NZ (1) NZ257843A (sk)
PL (1) PL179401B1 (sk)
RU (1) RU2115650C1 (sk)
SK (1) SK280522B6 (sk)
UA (1) UA41342C2 (sk)
WO (1) WO1994011360A1 (sk)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939412A (en) * 1992-06-26 1999-08-17 Smithkline Beecham Corporation Bicyclic fibrinogen antagonists
PT100631B (pt) * 1991-06-28 1999-06-30 Smithkline Beecham Corp Antagonistas biciclicos de fibrinogenio, seu uso e composicoes farmaceuticas que os contem
MA23420A1 (fr) * 1994-01-07 1995-10-01 Smithkline Beecham Corp Antagonistes bicycliques de fibrinogene.
US6458784B1 (en) 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
GB9506382D0 (en) * 1995-03-29 1995-05-17 Boots Co Plc Pharmaceutical compositions
US5977101A (en) * 1995-06-29 1999-11-02 Smithkline Beecham Corporation Benzimidazoles/Imidazoles Linked to a Fibrinogen Receptor Antagonist Template Having Vitronectin Receptor Antagonist Activity
ZA9610853B (en) 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
GB9616279D0 (en) * 1996-08-02 1996-09-11 Knoll Ag Chemical process
PT864582E (pt) * 1997-03-14 2003-10-31 Aventis Pharma Gmbh 1,4-benzotiazepina-1,1-dioxidos hipolipidemicos
GB9914745D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7393652B2 (en) 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US7879840B2 (en) 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
AU2004220548A1 (en) 2003-03-07 2004-09-23 The Trustees Of Columbia University, In The City Of New York Type 1 ryanodine receptor-based methods
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
ME01989B (me) 2008-03-03 2012-08-31 Servier Lab Postupak za proizvodnju benzotiazepina od gama-aminoalkilbenzena
WO2013064231A1 (en) 2011-10-31 2013-05-10 Phenex Pharmaceuticals Ag SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
EP2708535A1 (en) * 2012-05-11 2014-03-19 Les Laboratoires Servier Agents for treating disorders involving modulation of ryanodine receptors
KR102157141B1 (ko) 2018-11-27 2020-09-17 주식회사 파미니티 으아리 추출물을 유효 성분으로 포함하는 인지 기능 개선용 조성물
KR102172916B1 (ko) 2018-12-07 2020-11-02 주식회사 파미니티 실크 펩타이드 및 천연 추출물을 포함하는 인지 기능 개선용 조성물
JP2023549583A (ja) * 2020-11-17 2023-11-27 アームゴ・ファーマ・インコーポレーテッド リアノジン受容体関連障害治療用薬剤
JP2024503045A (ja) 2021-01-08 2024-01-24 アームゴ・ファーマ・インコーポレーテッド リアノジン受容体調節因子の結晶形態およびその使用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362962A (en) * 1964-01-24 1968-01-09 Hoffmann La Roche Certain benzothiazepine derivatives
US3682962A (en) * 1970-03-17 1972-08-08 Sterling Drug Inc 1-substituted-1,2,3,5-tetrahydro-4,1-benzothiozepines
DE58901634D1 (de) * 1988-11-05 1992-07-16 Bayer Ag Verfahren zur kernchlorierung von aromatischen kohlenwasserstoffen.
JP2703408B2 (ja) * 1990-12-28 1998-01-26 麒麟麦酒株式会社 １，４‐ベンゾチアゼピン誘導体
GB9111376D0 (en) * 1991-05-25 1991-07-17 Boots Co Plc Therapeutic agents
GB9203347D0 (en) * 1992-02-17 1992-04-01 Wellcome Found Hypolipidaemic compounds

Also Published As

Publication number Publication date
JPH08503202A (ja) 1996-04-09
NO304467B1 (no) 1998-12-21
FI952204A (fi) 1995-05-08
WO1994011360A1 (en) 1994-05-26
HUT71819A (en) 1996-02-28
GR3026386T3 (en) 1998-06-30
FI952204A0 (fi) 1995-05-08
NZ257843A (en) 1996-10-28
KR100313649B1 (ko) 2002-02-28
PL308757A1 (en) 1995-08-21
BR9307387A (pt) 1999-08-31
RU2115650C1 (ru) 1998-07-20
RU95112484A (ru) 1997-04-20
AU680639B2 (en) 1997-08-07
HU9501352D0 (en) 1995-06-28
NO951797L (no) 1995-05-24
SK280522B6 (sk) 2000-03-13
BG62519B1 (bg) 2000-01-31
CZ117695A3 (en) 1996-06-12
ES2113081T3 (es) 1998-04-16
US5580866A (en) 1996-12-03
DE69317436T2 (de) 1998-07-02
ATE163927T1 (de) 1998-03-15
DE69317436D1 (de) 1998-04-16
PL179401B1 (pl) 2000-08-31
KR950704283A (ko) 1995-11-17
CZ288595B6 (cs) 2001-07-11
UA41342C2 (uk) 2001-09-17
EP0667866B1 (en) 1998-03-11
CA2148584A1 (en) 1994-05-26
BG99679A (bg) 1996-04-30
SK58895A3 (en) 1995-09-13
AU5464494A (en) 1994-06-08
EP0667866A1 (en) 1995-08-23
NO951797D0 (no) 1995-05-08

Similar Documents

Publication Publication Date Title
DK0667866T3 (da) 1,4-benzothiazepiner anvendelige som neurologiske midler
PL323666A1 (en) Semicarbasones acting on central nervous system and pharmaceutic agents containing them
FI961630A (fi) Terapeuttisia aineita
ATE225205T1 (de) Dispergiermittel
ATE168991T1 (de) Substituierte arylalkoxybenzyl-aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
ZA943241B (en) Therapeutic agents
IL107486A0 (en) Therapeutic agents
ES2087813A1 (es) Heterociclos no-aromaticos que contienen nitrogeno bencilamino substituidos.
JO1785B1 (en) Therapeutic agents